HealthpointCapital Announces Appointment of Milen Todorov as Managing Director

NEW YORK, Feb. 7, 2018 /PRNewswire/ -- HealthpointCapital, the leading private equity firm focused exclusively on the Musculoskeletal sector, announced that Milen Todorov, a former medical technology investment banker at UBS Investment Bank, has joined the firm's leadership team as Managing Director.

Prior to joining HealthpointCapital, Milen Todorov was a Director in the global healthcare team at UBS Investment Bank, focusing on medical technology, and on the musculoskeletal sector in particular. While at UBS, Milen executed over 25 M&A and capital raising transactions with aggregate value in excess of $35 billion. He began his career in economic litigation consulting at Charles River Associates. Mr. Todorov holds a B.A. in Economics from Middlebury College and an MBA from the Tuck School of Business at Dartmouth.

Milen joins the experienced team at HealthpointCapital, led by John Foster, Chairman, and Mike Mogul, President. Foster is a leader in healthcare private equity investing with over 38 years of experience, including nine previous PE funds. It was Foster's vision to focus HealthpointCapital's investment strategy on the attractive Musculoskeletal sector, covering Orthopaedics, Dental, Maxillofacial, Rehabilitation, and the related, rapidly changing information systems supporting both providers and patients. HealthpointCapital is raising its fourth musculoskeletal-focused fund following the Company's outstanding track record from the three funds raised over the past 15 years.

"Milen brings strong transaction execution experience, as well as deep sector knowledge and relationships," said John Foster, Chairman of HealthpointCapital. "His addition further strengthens our very experienced investment team that is actively investing and mentoring companies in the musculoskeletal sector."

The HealthpointCapital team also includes:

    --  Mike Mogul, President and Managing Director.  Before joining
        HealthpointCapital in 2017, Mr. Mogul served as CEO of DJO Global, a
        $1bn, PE-owned company in the orthopaedics sector, for six years. Prior
        to that, he was Group President, Orthopaedics at Stryker. Additionally,
        during his 22 years at Stryker, he ran all of the company's divisional
        segments in Germany, Austria and Switzerland.
    --  Laing F. Rikkers, Managing Director. Ms. Rikkers' principal role is
        identifying investment opportunities, determining strategies and
        developing portfolio organizations. She has been at HealthpointCapital
        for 14 years, serves as Chairman of ProSomnus Sleep Technologies and is
        a former Director at BioHorizons.
    --  William Johnson, Managing Director and CFO. He was previously CEO & CFO
        of MicroDental, Inc., a former HealthpointCapital portfolio company. Mr.
        Johnson has over 20 years in senior management roles primarily with
        private equity controlled companies, and early career experience with
        Abbey Medical (now Apria Healthcare) and American Hospital Supply
        Corporation.
    --  David L. Helfet MD, Senior Advisor. Dr. Helfet is Professor of
        Orthopaedics at Weill Cornell College, and Director Emeritus of the
        Orthopaedic Trauma Service at Hospital for Special Surgery and New York
        Presbyterian Hospital. Dr. Helfet has been a member of
        HealthpointCapital's leadership team for 16 years and served on the
        board of Synthes, prior to its acquisition by Johnson & Johnson.
    --  Richard N. Foster, Senior Advisor. Dr. Foster is Chairman of the Board
        at Ancera Diagnostics, and Director at Advantia Health, LeanTaas
        Analytics, ZocDoc, DrFirst, SQream Computers and Memorial
        Sloan-Kettering Cancer Center. Dr. Foster is also Director Emeritus at
        McKinsey & Company where he was one of the founders of their Healthcare
        practice. He has been a member of HealthpointCapital's leadership team
        for the last 9 years
    --  Richard H. Rothman, M.D., Ph.D., Senior Advisor. Dr. Rothman is
        Professor of Orthopaedic Surgery at Thomas Jefferson University Medical
        School, is Co-Chairman Board of Trustees of Thomas Jefferson University
        and the founder of the Rothman Institute, one of the leading Orthopaedic
        Centers. In addition to his practice of orthopaedic surgery, he has also
        served as the Editor-in-Chief of The Journal of Arthroplasty, which is
        the most widely read peer-reviewed journal dedicated to total joint
        replacement. His business interests include founding and acting as
        Chairman of the Board of Specialty Care Network, a publicly held company
        now known as Healthgrades. He serves as a member of several corporate
        boards and has served as a Private Equity advisor for the Carlyle Group
        and the Riverside Company.

HealthpointCapital is the leading private equity firm focused exclusively on musculoskeletal and currently has $800 million under investment. It is raising its fourth fund targeting innovative and exciting emerging businesses and established companies that can benefit from its sector focus, mentorship and investment. It will also seek out established but under-nourished segments and products within major MedTech firms that have the potential to flourish with the addition of HealthpointCapital's musculoskeletal leadership experience and investment. HealthpointCapital's team will be attending next month's American Academy of Orthopaedic Surgeons meeting in New Orleans. Please contact us for more information at www.healthpointcapital.com.

For investor or media inquiries please contact:
Blake Mossy, HealthpointCapital, 212-935-7780 or bmossy@healthpointcapital.com

View original content:http://www.prnewswire.com/news-releases/healthpointcapital-announces-appointment-of-milen-todorov-as-managing-director-300595151.html

SOURCE HealthpointCapital